Thousand Oaks, CA, United States of America

Yue-Sheng “Luke” Li

This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yue-Sheng “Luke” Li. Retrieved from https://idiyas.com/inventor/yue-sheng-“luke”-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Yue-Sheng “Luke” Li

Introduction

Yue-Sheng “Luke” Li is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on addressing diseases mediated by human interferon-gamma (IFN-γ).

Latest Patents

Yue-Sheng Li holds a patent titled "Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors." This invention provides antibodies that interact with or bind to human interferon-gamma and methods for treating IFN-γ mediated diseases by administering a pharmaceutically effective amount of these antibodies. Additionally, the patent includes methods for detecting the amount of IFN-γ in a sample using antibodies to IFN-γ. He has 1 patent to his name.

Career Highlights

Yue-Sheng Li is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen focuses on innovative solutions to complex medical challenges, particularly in the realm of immune response modulation.

Collaborations

Some of his notable coworkers include Andrew A Welcher and Hilary T Chute, who contribute to the collaborative environment at Amgen Inc. Their combined expertise enhances the research and development efforts within the company.

Conclusion

Yue-Sheng “Luke” Li's contributions to biotechnology through his patent on IFN-γ neutralizing antibodies exemplify the innovative spirit of modern inventors. His work continues to pave the way for advancements in treating immune-mediated diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…